Literature DB >> 18683867

Arterialized venous free flap for reconstruction of burned face.

Martín Iglesias1, Patricia Butrón, Claudia Chávez-Muñoz, Iván Ramos-Sánchez, Alexandra Barajas-Olivas.   

Abstract

In this study, a forearm arterialized venous free flap (23 cm x 14 cm) was used in a 25-year-old male with facial burns sequels to reconstruct both cheeks, chin, lips, nose, columnella, nasal tip, and nostrils. It was arterialized by the facial artery to an afferent vein anastomosis. The venous flow was drained by four efferent vein to vein anastomoses. Although it developed small inferior marginal necrosis in the lower lip, the rest of the flap survived with good quality of the skin in both texture and color, with self-delimitation of the different esthetics units of the center of the face such as the nasogenian folds, nostrils, and upper lip filtrum, without the need of additional thinning surgical procedures. From all of the above, the arterialized venous free flap is an alternative reconstructive option for the treatment of burn sequels especially those that include the centrofacial region. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18683867     DOI: 10.1002/micr.20525

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  3 in total

Review 1.  Severe burn injuries: acute and long-term treatment.

Authors:  Timo A Spanholtz; Panagiotis Theodorou; Peymaneh Amini; Gerald Spilker
Journal:  Dtsch Arztebl Int       Date:  2009-09-18       Impact factor: 5.594

2.  Use of Vascularized Sural Nerve Grafts for Sciatic Nerve Reconstruction After Malignant Bone and Soft Tissue Tumor Resection in the Lower Legs.

Authors:  Hideki Tokumoto; Shinsuke Akita; Yoshitaka Kubota; Motone Kuriyama; Nobuyuki Mitsukawa
Journal:  Ann Plast Surg       Date:  2018-04       Impact factor: 1.539

3.  Arterialized Venous Bone Flaps: An Experimental Investigation.

Authors:  Farzad Borumandi; James P Higgins; Heinz Buerger; Anna Vasilyeva; Memmet Emre Benlidayi; Leman Sencar; Alexander Gaggl
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.